Michael Rosenzweig, MD, Oncology, Duarte, CA, City of Hope's Helford Clinical Research Hospital

MichaelA.RosenzweigMD

Oncology Duarte, CA

Hematologic Oncology

Assistant Professor

Dr. Rosenzweig is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rosenzweig's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Bone Marrow Transplantation, 2009 - 2011
  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology/Oncology, 2006 - 2009
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 2001 - 2004
  • University of Arizona College of Medicine - Tucson
    University of Arizona College of Medicine - TucsonClass of 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2023
  • NY State Medical License
    NY State Medical License 2009 - 2013
  • MA State Medical License
    MA State Medical License 2004 - 2011
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • First-in-Human Imaging of Multiple Myeloma Using Copper-64-Labeled Daratumumab: Preliminary Results
    Michael Rosenzweig, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Novel Approaches Emerge in AL Amyloidosis
    Novel Approaches Emerge in AL AmyloidosisApril 27th, 2018
  • Working Together
    Working TogetherOctober 10th, 2017
  • Recommendations from FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials
    Recommendations from FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical TrialsApril 10th, 2021

Hospital Affiliations